SEC Form 8-K: Item 8.01 Other Events

Bio-Path Holdings Presents Data from Ongoing Phase 2 Study of Prexigebersen at 2021 American Society of Hematology Annual Meeting

SEC Form 8-K: Press Release Dated December 13, 2021

Bio-Path Holdings Reports Third Quarter 2021 Financial Results

SEC Form 8-K: Press Release Dated November 12, 2021

SEC Form 10-Q for period ending September 30, 2021

Bio-Path Holdings to Announce Third Quarter 2021 Financial Results on November 12, 2021

Bio-Path Holdings to Present Clinical Data at the 63rd Annual American Society of Hematology Annual Meeting

SEC Form Schedule 14A: Proxy Materials

SEC Form Schedule 14A: Notice of Annual Meeting